益生元
肠道菌群
合生元
益生菌
鼠李糖乳杆菌
肠-脑轴
肠道微生物群
自闭症谱系障碍
病因学
医学
自闭症
双歧杆菌
胃肠道疾病
临床试验
生物信息学
乳酸菌
免疫学
内科学
生物
精神科
遗传学
细菌
作者
Omar Cauli,José Guevara-González,José Guevara-Campos,Lucía González
出处
期刊:Current reviews in clinical and experimental pharmacology
[Bentham Science]
日期:2021-08-06
卷期号:17 (3): 166-173
被引量:3
标识
DOI:10.2174/2772432816666210805141257
摘要
Autism Spectrum Disorders (ASDs) are a group of prevalent neuropsychiatric disorders. They present a complex and unknown etiology, which in most cases includes significant peripheral alterations outside the brain such as in the composition of gut microbiota. Because the gut microbiota is involved in modulating the gut-brain axis, several studies have suggested that the microbiome in the gut can modify metabolites which are able to cross the blood-brain barrier and modulate brain function.We reviewed the current evidence regarding microbiota alterations in patients with ASD and the effects of the administration of probiotics and prebiotics in these patients, both in terms of gastrointestinal and behavioural symptoms.Administration of a probiotic formulation containing different strains of Lactobacillus (L. acidophilus, L. rhamnosus, and others) and Bifidobacteria had beneficial effects upon these aforementioned symptoms and their use is recommended in a subgroup of ASD patients that present gastrointestinal disturbances. Nonetheless, the types of gastrointestinal disturbances that most benefit from such interventions remain to be elucidated in order to personalize the medical approaches.Recent clinical studies have shown that probiotic treatments can regulate the gut microbiota and may result in improvements in some behavioral abnormalities associated with ASD. Trials using prebiotic fibers or synbiotics preparations are still lacking and necessary in order to deep in such therapeutic strategies in ASD with comorbid gastrointestinal disrturbances.
科研通智能强力驱动
Strongly Powered by AbleSci AI